LONDON, June 4, 2018 /PRNewswire/ --
Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation,today announces that Jonathan Peacock, Chairman, will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, 6 June at 10:00am EDT.
About Arix Bioscience plc
Arix Bioscience plc is a global healthcare
Arix Bioscience plc is listed on the Main Market of the London Stock Exchange.
For more information, please contact: Arix Bioscience plc Charlotte Parry, Investors Relations Manager +44(0)20-7290-1072 firstname.lastname@example.org Burns McClellan Lisa Burns, John Grimaldi, Bill Slattery Jr. +1-212-213-0006 email@example.com
SOURCE Arix Bioscience plc
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All